These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
662 related articles for article (PubMed ID: 33535238)
21. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?]. Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F; Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811 [TBL] [Abstract][Full Text] [Related]
22. The Positive Rhinovirus/Enterovirus Detection and SARS-CoV-2 Persistence beyond the Acute Infection Phase: An Intra-Household Surveillance Study. Brotons P; Jordan I; Bassat Q; Henares D; Fernandez de Sevilla M; Ajanovic S; Redin A; Fumado V; Baro B; Claverol J; Varo R; Cuadras D; Hecht J; Barrabeig I; Garcia-Garcia JJ; Launes C; Muñoz-Almagro C Viruses; 2021 Aug; 13(8):. PubMed ID: 34452462 [TBL] [Abstract][Full Text] [Related]
23. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept. Rusanen J; Kareinen L; Szirovicza L; Uğurlu H; Levanov L; Jääskeläinen A; Ahava M; Kurkela S; Saksela K; Hedman K; Vapalahti O; Hepojoki J mBio; 2021 May; 12(3):. PubMed ID: 34006662 [TBL] [Abstract][Full Text] [Related]
24. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection. Gerhards C; Thiaucourt M; Kittel M; Becker C; Ast V; Hetjens M; Neumaier M; Haselmann V Int J Infect Dis; 2021 Jun; 107():221-227. PubMed ID: 33932604 [TBL] [Abstract][Full Text] [Related]
25. Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients. Tutuncu EE; Ozgur D; Karamese M J Med Virol; 2021 May; 93(5):2932-2937. PubMed ID: 33501645 [TBL] [Abstract][Full Text] [Related]
27. Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea. Park S; Chang SH; Lee JH; Lee JH; Ham JY; Kim YK; Kim SG; Ryoo NH PLoS One; 2022; 17(1):e0262820. PubMed ID: 35051239 [TBL] [Abstract][Full Text] [Related]
28. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients. Li L; Liang Y; Hu F; Yan H; Li Y; Xie Z; Huang L; Zhao J; Wan Z; Wang H; Shui J; Cai W; Tang S Virology; 2020 Dec; 551():26-35. PubMed ID: 33011520 [TBL] [Abstract][Full Text] [Related]
29. Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England. Wells PM; Doores KJ; Couvreur S; Nunez RM; Seow J; Graham C; Acors S; Kouphou N; Neil SJD; Tedder RS; Matos PM; Poulton K; Lista MJ; Dickenson RE; Sertkaya H; Maguire TJA; Scourfield EJ; Bowyer RCE; Hart D; O'Byrne A; Steel KJA; Hemmings O; Rosadas C; McClure MO; Capedevilla-Pujol J; Wolf J; Ourselin S; Brown MA; Malim MH; Spector T; Steves CJ J Infect; 2020 Dec; 81(6):931-936. PubMed ID: 33068628 [TBL] [Abstract][Full Text] [Related]
30. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561 [TBL] [Abstract][Full Text] [Related]
31. Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations. Fan G; Qin X; Streblow DN; Hoyos CM; Hansel DE Microbiol Spectr; 2021 Sep; 9(1):e0006221. PubMed ID: 34431689 [TBL] [Abstract][Full Text] [Related]
32. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. Lumley SF; O'Donnell D; Stoesser NE; Matthews PC; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Warren F; Peck LJ; Ritter TG; de Toledo Z; Warren L; Axten D; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Chand M; Crook DW; O'Donnell AM; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Hopkins S; Walker TM; Jeffery K; Eyre DW; N Engl J Med; 2021 Feb; 384(6):533-540. PubMed ID: 33369366 [TBL] [Abstract][Full Text] [Related]
33. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand. Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528 [TBL] [Abstract][Full Text] [Related]
34. The seroprevalence of SARS-CoV-2 in a rural southwest community. Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087 [TBL] [Abstract][Full Text] [Related]
35. A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization. Peterhoff D; Glück V; Vogel M; Schuster P; Schütz A; Neubert P; Albert V; Frisch S; Kiessling M; Pervan P; Werner M; Ritter N; Babl L; Deichner M; Hanses F; Lubnow M; Müller T; Lunz D; Hitzenbichler F; Audebert F; Hähnel V; Offner R; Müller M; Schmid S; Burkhardt R; Glück T; Koller M; Niller HH; Graf B; Salzberger B; Wenzel JJ; Jantsch J; Gessner A; Schmidt B; Wagner R Infection; 2021 Feb; 49(1):75-82. PubMed ID: 32827125 [TBL] [Abstract][Full Text] [Related]
36. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients. Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394 [TBL] [Abstract][Full Text] [Related]
37. Immunological assessment of SARS-CoV-2 infection in pregnancy from diagnosis to delivery: A multicentre prospective study. Glennon K; Donnelly J; Knowles S; McAuliffe FM; O'Reilly A; Corcoran S; Walsh J; McMorrow R; Higgins T; Bolger L; Clinton S; O'Riordan S; Start A; Roche D; Bartels H; Malone C; McAuley K; McDermott A; Inzitari R; O'Donnell CPF; Malone F; Higgins S; De Gascun C; Doran P; Brennan DJ PLoS One; 2021; 16(9):e0253090. PubMed ID: 34543278 [TBL] [Abstract][Full Text] [Related]
38. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test. Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511 [TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study. Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ; J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924 [TBL] [Abstract][Full Text] [Related]
40. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China. Feng X; Yin J; Zhang J; Hu Y; Ouyang Y; Qiao S; Zhao H; Zhang T; Li X; Zhang L; Zhang J; Jin R; Feng Y; Su B Front Immunol; 2021; 12():614436. PubMed ID: 33790892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]